In summary, our current study elucidated that wogonoside could prevent colitis-associated colorectal carcinogenesis and inhibit colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway. The gene discussed is AKT1; the disease is colonic neoplasm.